KLF2

KLF2, also known as Krüppel-like factor 2, is a transcription factor that plays a crucial role in B cell differentiation. Its full name is Krüppel-like factor 2. KLF2 functions by inhibiting the transcriptional activity of NF-κB and activator protein 1, partially through the recruitment of transcriptional coactivator p300/CBP-associated factor. It is involved in various signaling pathways, including adipogenesis, atherosclerosis, thrombosis, asthma, and arthritis. Research on KLF2 has led to potential therapeutic targets for these diseases, with ongoing drug development efforts focusing on modulating its activity.
KLF2 has emerged as a key regulator in multiple physiological processes, with its dysregulation linked to various diseases. Beyond its role in B cell differentiation, KLF2 is implicated in metabolic diseases, inflammatory disorders, and cancers. Current research aims to understand the precise mechanisms of KLF2 action and to develop novel therapeutic strategies that target this protein to treat related diseases.